BIO FY 2006 Earnings Report — Bio-Rad Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

Bio-Rad Laboratories, Inc.BIO

FY 2006 Earnings

Reported February 28, 2007

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2006	Prior Q	FY 2005	QoQ Change	YoY Change
Revenue	$1.3B	—	—	—	—
Op. Income	$146M	—	—	—	—
Gross Margin	55.9%	—	—	—	—
Net Margin	8.1%	—	—	—	—
EPS (Diluted)	$3.83	—	—	—	—
Free Cash Flow	$65M	—	—	—	—

Revenue Flow

Item	Amount
REVENUE	$1.3B
Cost of Revenue	$561M
GROSS PROFIT	$713M
R&D Expenses	$123M
Selling & Marketing	$0
General & Administrative	$439M
SG&A Expenses	$439M
Other Expenses	$0
Operating Expenses	$562M
Cost & Expenses	$1.1B
OPERATING INCOME	$146M
Interest Income	$0
Interest Expense	$32M
Other Income/Expenses	-$4M
INCOME BEFORE TAX	$142M
Income Tax Expense	$39M
Net Income from Continuing Ops	$103M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$103M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$103M
D&A	$55M
EBIT	$174M
EBITDA	$229M
EPS	$4
EPS Diluted	$4

Income Statement

Item	Amount
REVENUE	$1.3B
Cost of Revenue	$561M
GROSS PROFIT	$713M
R&D Expenses	$123M
Selling & Marketing	$0
General & Administrative	$439M
SG&A Expenses	$439M
Other Expenses	$0
Operating Expenses	$562M
Cost & Expenses	$1.1B
OPERATING INCOME	$146M
Interest Income	$0
Interest Expense	$32M
Other Income/Expenses	-$4M
INCOME BEFORE TAX	$142M
Income Tax Expense	$39M
Net Income from Continuing Ops	$103M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$103M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$103M
D&A	$55M
EBIT	$174M
EBITDA	$229M
EPS	$4
EPS Diluted	$4

Cash Flow Statement

Item	Amount
Net Income	$103M
Depreciation & Amortization	$55M
Stock-Based Compensation	$5M
Deferred Income Tax	$1M
Other Non-Cash Items	-$37M
Change in Working Capital	-$10M
OPERATING CASH FLOW	$118M
Capital Expenditure	-$53M
Acquisitions (Net)	-$46M
Purchases of Investments	-$334M
Sales/Maturities of Investments	$179M
Other Investing Activities	$47M
NET CASH FROM INVESTING	-$208M
Net Debt Issuance	-$1M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	$1M
NET CASH FROM FINANCING	$10M
FREE CASH FLOW	$65M
Net Change in Cash	-$73M

Balance Sheet

Item	Amount
Cash & Equivalents	$224M
Short-Term Investments	$264M
Net Receivables	$293M
Inventory	$253M
Other Current Assets	$36M
TOTAL CURRENT ASSETS	$1.1B
PP&E (Net)	$190M
Goodwill	$119M
Intangible Assets	$45M
Long-Term Investments	$0
Tax Assets	$9M
Other Non-Current Assets	$104M
TOTAL NON-CURRENT ASSETS	$466M
TOTAL ASSETS	$1.6B
Account Payables	$83M
Short-Term Debt	$3M
Deferred Revenue	$0
Other Current Liabilities	$100M
TOTAL CURRENT LIABILITIES	$320M
Long-Term Debt	$426M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$8M
Other Non-Current Liabilities	$24M
TOTAL NON-CURRENT LIABILITIES	$457M
TOTAL LIABILITIES	$777M
Common Stock	$3.0K
Additional Paid-In Capital	$78M
Retained Earnings	$674M
Treasury Stock	$0
Accum. Other Comp. Income	$67M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$820M
Minority Interest	$0
TOTAL EQUITY	$820M
TOTAL LIABILITIES & EQUITY	$1.6B
Total Debt	$429M
Net Debt	$205M